Ohio’s House of Representatives passed a measure on Wednesday designed to curb women from obtaining mail-order chemical abortions.
House Bill 324, called the Patient Protection Act, passed by a vote of 59-28 after exiting the committee earlier in the day. According to LifesNews:
House Bill 324, dubbed the Patient Protection Act, cleared the chamber 59-28. The legislation would classify the abortion drug mifepristone as a “dangerous drug” due to its severe side effects in more than 5% of patients. It prohibits mail-order sales and remote prescribing, requiring women to visit a doctor in person for informed consent about the risks.
Companion bill House Bill 485, the Baby Olivia Act, passed 58-26. The measure mandates human growth and development instruction in public school health classes, incorporating an ultrasound video and the 3-minute animated film “Meet Baby Olivia,” which depicts prenatal development from fertilization to birth.
Critics of the bill say the restrictions are too broad, and would bar many non-abortive drugs from being accessed.
Planned Parenthood has come out swinging against the measure, describing it as “a dangerous attempt by Ohio lawmakers to insert extremism into the exam room” and insisting that “this bill forces doctors to deliver state-mandated medical misinformation.”
They also lament:
